→
STERIS plc
STERIS plc (STE) currently trades at $222.58, reflecting a slight decline of 0.52% from its previous close of $223.75. Despite a year-over-year EPS growth of 52.18%, the company missed Q3 2026 earnings estimates by $0.03, which raises concerns about future performance. With a P/E ratio of 30.83, STE appears overvalued compared to its revenue growth of only 7.96%, indicating potential headwinds ahead.
Investors should consider reducing exposure to STERIS plc due to valuation concerns and recent earnings performance.
A Look At STERIS (STE) Valuation After Recent Share Price Weakness And Long Term Gains
2026-04-10
Is This the Right Time to Hold STERIS Stock in Your Portfolio?
2026-04-08
Steris PLC stock outperforms competitors despite losses on the day
2026-03-27
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes your holdings, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates STE as Bearish. Investors should consider reducing exposure to STERIS plc due to valuation concerns and recent earnings performance.
The recent earnings miss of $0.03 against estimates raises concerns about operational efficiency moving forward, particularly as the P/S ratio stands at 3.74, suggesting a premium valuation that may not be sustainable. With a current ratio of 2.48, while liquidity appears strong, any decline in revenue could strain financial stability.
If STERIS can leverage its strong EPS growth of 52.18% to improve revenue growth beyond 7.96%, it could justify its high P/E ratio. Additionally, the analyst consensus shows 10 out of 15 ratings as 'Buy' or 'Strong Buy', indicating potential upside if market conditions improve.
STERIS plc (STE) currently trades at $222.58, reflecting a slight decline of 0.52% from its previous close of $223.75. Despite a year-over-year EPS growth of 52.18%, the company missed Q3 2026 earnings estimates by $0.03, which raises concerns about future performance. With a P/E ratio of 30.83, STE appears overvalued compared to its revenue growth of only 7.96%, indicating potential headwinds ahead.
STERIS plc (STE) currently trades at $222.58, reflecting a slight decline of 0.52% from its previous close of $223.75. Despite a year-over-year EPS growth of 52.18%, the company missed Q3 2026 earnings estimates by $0.03, which raises concerns about future performance. With a P/E ratio of 30.83, STE appears overvalued compared to its revenue growth of only 7.96%, indicating potential headwinds ahead. Our overall verdict is Bearish.
Helm Terminal offers free AI-powered stock analysis for STE at helmterminal.dev/analyze/STE, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.